Clinical Trial Update: Assessing Cosopt Switch Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating outcomes for patients switched to Cosopt (dorzolamide-timolol) in ocular hypertension and several glaucoma subtypes,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exfoliation Syndrome
• Ocular Hypertension
• Open-angle Glaucoma
• Pigmentary Glaucoma

Drugs mentioned

• Cosopt (dorzolamide/timolol)

Snippet

Sponsor: Pharmaceutical Research Network | Conditions: Ocular Hypertension, Open-Angle Glaucoma | Phase 4 | Status: COMPLETED